Latest news with #SBILifeInsuranceCompany
Time of India
10 hours ago
- Business
- Time of India
SBI Life Q1FY26 results preview: APE may grow up to 8% YoY, VNB could surge up to 17%
SBI Life Insurance Company is set to announce its Q1 earnings on Thursday, July 24. The public sector insurer is expected to report a 2%–8% year-on-year growth in Annual Premium Equivalent ( APE ), which is likely to fall in the range of Rs 3,720 crore to Rs 3,936 crore. The Value of New Business ( VNB ) is projected to rise 2% to 17%, according to estimates from four brokerages , placing it between Rs 993 crore and Rs 1,133 crore. However, margins are expected to take a hit, both year-on-year and sequentially. Explore courses from Top Institutes in Please select course: Select a Course Category CXO healthcare Technology PGDM Degree Data Science MCA Digital Marketing Project Management Public Policy Management Leadership Artificial Intelligence Product Management Data Analytics Others Cybersecurity Healthcare Design Thinking Operations Management MBA Data Science others Finance Skills you'll gain: Operations Strategy for Business Excellence Organizational Transformation Corporate Communication & Crisis Management Capstone Project Presentation Duration: 11 Months IIM Lucknow Chief Operations Officer Programme Starts on Jun 30, 2024 Get Details Skills you'll gain: Digital Strategy Development Expertise Emerging Technologies & Digital Trends Data-driven Decision Making Leadership in the Digital Age Duration: 40 Weeks Indian School of Business ISB Chief Digital Officer Starts on Jun 30, 2024 Get Details Skills you'll gain: Customer-Centricity & Brand Strategy Product Marketing, Distribution, & Analytics Digital Strategies & Innovation Skills Leadership Insights & AI Integration Expertise Customer-Centricity & Brand Strategy Product Marketing, Distribution, & Analytics Digital Strategies & Innovation Skills Leadership Insights & AI Integration Expertise Duration: 10 Months IIM Kozhikode IIMK Chief Marketing and Growth Officer Starts on Apr 7, 2024 Get Details Skills you'll gain: Customer-Centricity & Brand Strategy Product Marketing, Distribution, & Analytics Digital Strategies & Innovation Skills Leadership Insights & AI Integration Expertise Duration: 10 Months IIM Kozhikode IIMK Chief Marketing and Growth Officer Starts on Apr 7, 2024 Get Details Skills you'll gain: Technology Strategy & Innovation Emerging Technologies & Digital Transformation Leadership in Technology Management Cybersecurity & Risk Management Duration: 24 Weeks Indian School of Business ISB Chief Technology Officer Starts on Jun 28, 2024 Get Details Estimates from Axis Securities, YES Securities, Nuvama Institutional Equities, and PhillipCapital have been considered for this analysis. Brokerages suggest that investors should closely watch VNB margin trends, growth commentary, and any changes in product mix. Here's what each brokerage forecasts: Axis Securities Axis expects Gross Premium Earned to rise 13.8% YoY to Rs 17,723 crore, but fall 26.2% QoQ. New Business Premium (NBP) is estimated at Rs 7,953 crore, up 13.1% YoY but down 14.7% QoQ. The APE is projected at Rs 3,936 crore, up 8.1% YoY and down 27.8% QoQ. The VNB is seen at Rs 1,132 crore, a 16.7% YoY increase but 31.8% QoQ drop. VNB margin is estimated at 28.8%, expanding 195 bps YoY, but narrowing 175 bps QoQ. Axis expects SBI Life to maintain its cost leadership. Monitorables include VNB margin outlook, growth commentary, and changes in product mix. YES Securities YES Securities forecasts an APE of Rs 3,913 crore, an 8% YoY increase but a 28% QoQ decline. NBP is expected at Rs 8,044 crore, showing 14% YoY growth, but falling 14% QoQ—indicating seasonal moderation. VNB is likely to be Rs 1,133 crore, up 17% YoY but down 32% QoQ. The brokerage notes a VNB margin contraction of 150 bps QoQ, based on observed product mix shifts and weak growth trends in April and May 2025. Nuvama Institutional Equities Nuvama pegs APE at Rs 3,720 crore, up just 2% YoY, but sharply down 32% QoQ. VNB is estimated at Rs 993 crore, reflecting the same 2% YoY growth and a steep 40% QoQ drop. VNB margin is expected to remain flat YoY at 27%, but fall 12% sequentially. The brokerage says management commentary on growth and bank-channel distribution will be key to monitor. PhillipCapital PhillipCapital expects PAT of Rs 582 crore, up 12% YoY but sharply down 28% QoQ. Revenue is seen at Rs 3,858 crore, a 6% YoY rise but 29% lower QoQ. EBITDA is projected at Rs 6,465 crore, up 21% YoY, but down 23% QoQ. VNB is likely at Rs 1,020 crore, up 5% YoY, yet down 39% QoQ. VNB margin is pegged at 26.4%, indicating relative stability in profitability per policy. The brokerage expects APE to grow 6% YoY, driven by modest individual business growth. It expects VNB growth in line with APE, with flat margins YoY as a lower share of ULIP gets offset by a higher mix of group business.
Business Standard
03-07-2025
- Business
- Business Standard
Benchmarks end lower amid late sell-off; Nifty slips below 25,450
The headline equity indices closed with modest losses today, extending their losing streak for the second straight session. The Nifty 50, which climbed to an intraday high of 25,587.50 in the afternoon, eventually slipped to end below the 25,450 mark as profit booking in the final hour erased early gains. Supported by positive global cues, the market opened on a firm note and saw continued buying through the first half of the session. However, the rally lost steam toward the close, dragging key indices lower. Sector-wise, PSU bank and metal stocks came under pressure, while consumer durables and healthcare stocks provided some support with notable gains. The S&P BSE Sensex fell 170.22 points or 0.20% to 83,239.47. The Nifty 50 index lost 48.10 points or 0.19% to 25,405.30. In two consecutive sessions, the Sensex and Nifty are down by 0.54% and 0.53%, respectively. SBI Life Insurance Company (down 2.72%), Bajaj Finserv (down 1.38%) and Bajaj Finance (down 1.30%) were major drags. In the broader market, the S&P BSE Mid-Cap index shed 0.06% and the S&P BSE Small-Cap index rose 0.47%. The market breadth was positive. On the BSE, 2009 shares rose and 2001 shares fell. A total of 158 shares were unchanged. The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, shed 0.48% to 12.39. Economy: The seasonally adjusted HSBC India Services PMI Business Activity Index based on a single question asking how the level of business activity compares with the situation the month before rose from 58.8 in May to a ten-month high of 60.4 in June. The HSBC India Composite PMI Output Index rose from 59.3 in May to 61.0, indicating the fastest rate of expansion in 14 months. India-US trade deal update: India and the United States are reportedly close to finalising an interim trade deal, with both sides aiming to seal it within the next 48 hours. Negotiations are underway in Washington, where Indias trade delegation has extended its stay to iron out key issues ahead of the July 9 deadline. Thats when the 90-day pause on the 26% US tariffs is scheduled to expire. Numbers to Track: The yield on India's 10-year benchmark federal paper added 0.19% to 6.300 from the previous close of 6.288. In the foreign exchange market, the rupee edged higher against the dollar. The partially convertible rupee was hovering at 85.3550 compared with its close of 85.6200 during the previous trading session. MCX Gold futures for 5 August 2025 settlement shed 0.14% to Rs 97,253. The US Dollar Index (DXY), which tracks the greenback's value against a basket of currencies, was up 0.01% to 96.44. The United States 10-year bond yield lost 0.84% to 4.254. In the commodities market, Brent crude for September 2025 settlement fell 19 cents or 0.26% to $68.93 a barrel. Global Markets: Most European stocks advanced on Thursday as investors awaited the release of U.S. jobs data. Most Asian shares ended higher after U.S announced trade deal with Vietnam. According to a post on Truth Social, the U.S. will slap a 20% tariff on Vietnamese imports, while Vietnam will impose "ZERO Tariff" on U.S. goods. The announcement comes as Trumps 90-day tariff reprieve nears its deadline. Back in the U.S., Wall Street closed on a mixed note. The Dow Jones dipped 0.02%, while the S&P 500 rose 0.47%, and the Nasdaq jumped 0.94%. Tesla made headlines with a sharp 5% rebound, recovering from the previous days drop triggered by another round of sparring between Trump and Elon Musk. The EV giant reported Q2 deliveries of 384,122 vehicles, down from 443,956 last year but beating analyst expectations. Meanwhile, U.S. private payrolls disappointed again. June saw a decline of 33,000 jobs, against expectations of a 99,000 gain. Mays figures were also revised down to 29,000, marking the weakest two-month stretch since early 2023. The soft labor data reflects employer caution and worker hesitation amid tariff-related economic jitters. All eyes are now on the upcoming nonfarm payrolls report, due Thursday, which could provide clues on the Feds next move on interest rates. Markets will wrap up early on Thursday ahead of the July 4 Independence Day holiday. New Listing: Shares of Indogulf Cropsciences settled at Rs 110.80 on the BSE, representing a discount of 0.18% compared with the issue price of Rs 111. The scrip was listed at 111, matching the initial public offer (IPO) price. The stock has hit a high of Rs 112.60 and a low of Rs 105.45. On the BSE, 8.19 lakh shares of the company were traded in the counter. Stocks in Spotlight: Tata Power fell 1.65% after the company disclosed that an international arbitration tribunal has partially ruled in favour of Kleros Capital Partners in an ongoing dispute. In a stock exchange filing dated 2 July 2025, Tata Power informed investors that the three-member tribunal, by a majority of two to one, has awarded Kleros damages amounting to $490.32 million, along with simple interest at the rate of 5.33% from 30 November 2020, until payment is made. Additionally, the tribunal awarded Kleros a further $8.29 million as legal costs, also carrying simple interest of 5.33% from 1 July 2025, until paid. The arbitration proceedings were initiated by Kleros in November 2020, and oral hearings concluded in February 2024. The award was received by Tata Power after business hours on 1 July 2025. Biocon rose 1.76% after the company said that Biocon Biologics has received the European Commission (EC) marketing authorisation in the European Union (EU) for Vevzuo and Evfraxy biosimilars of Denosumab. Arkade Developers jumped 4.01% after the company announced the acquisition of redevelopment rights of a strategically located society in Bangur Nagar, Goregaon West. The site offers a RERA saleable area of approximately 86,000 square feet and an estimated revenue potential of Rs 350 crore. Bajel Projects hit an upper circuit of 5% after the company secured a mega order from PowerGrid Corporation of India for a critical 400 kV transmission line project. According to the companys classification, a mega contract is valued between Rs 300 crore and Rs 400 crore. Rail Vikas Nigam shed 0.5%. The company said that its board has approved the appointment of Chandan Kumar Verma as chief financial officer (CFO) with effect from 2 July 2025. Avenue Supermarts (DMart) slipped 1.04%. The company announced that the total number of DMart stores as of 30 June 2025 stood at 424. It has reported standalone revenue of Rs 15,932.12 crore in the quarter ended 30 June 2025, recording a growth of 16.19% from Rs 13,711.87 crore posted in the same period a year ago. Punjab National Bank (PNB) fell 3.21%. The bank's domestic deposits increased 12.2% to Rs 15,36,871 crore as of June 2025 compared with Rs 13,69,916 crore posted in June 2024. Baazar Style Retail tumbled 8.46%. The company reported 36.99% growth in revenue to Rs 377.70 crore in Q1 FY26, compared with Rs 275.70 posted in Q1 FY25. Tata Power declined 1.65% after the company disclosed that an international arbitration tribunal has partially ruled in favour of Kleros Capital Partners in an ongoing dispute. The arbitration, conducted under the Singapore International Arbitration Centre (SIAC) rules, stems from claims made by Kleros that Tata Power breached confidentiality and non-circumvention clauses outlined in a Non-Disclosure Agreement. Mahindra & Mahindra Financial Services rose 0.29% after the company reported a 1% year-on-year increase in overall disbursements at Rs 12,800 crore for the first quarter. NBCC (India) lost 2.16%. The company said that it has signed a memorandum of understanding (MoU) with the National Film Development Corporation (NFDC), under the Ministry of Information and Broadcasting. IPO Update: The initial public offer (IPO) of Crizac received bids for 6,89,14,994 shares as against 2,58,36,909 shares on offer, according to stock exchange data at 16:45 IST on Thursday (3 July 2025). The issue was subscribed 2.67 times. The issue opened for bidding on Wednesday (2 July 2025) and it will close on Friday (04 July 2025). The price band of the IPO is fixed between Rs 233 and 245 per share. An investor can bid for a minimum of 61 equity shares and in multiples thereof.
Time of India
21-06-2025
- Business
- Time of India
Chhattisgarh State Consumer Commission orders SBI Life to pay Rs 50 lakh to widow, rejects concealment claim
RAIPUR: The Chhattisgarh State Consumer Disputes Redressal Commission has directed SBI Life Insurance Company to pay Rs 50 lakh to Savitri Salam, whose husband's insurance claim was initially rejected. The Commission found that the insurer failed to conclusively prove concealment of pre-existing diseases by the deceased. Savitri Salam, a resident of Surdongar village in Keshkal tehsil, filed a complaint after her husband's health deteriorated, leading to his demise on 16 June 2021. She had sought a claim under a policy taken by her husband, but SBI Life Insurance rejected it, alleging that he had provided incorrect information about his pre-existing medical conditions and treatment in the proposal form. The insurance company argued before the District Consumer Commission that the insured suffered from diabetes and heart disease prior to taking the policy, and this was noted in his medical records from AIIMS, Raipur, as part of his medical history. Based on this, the claim was rejected due to misrepresentation of health information in the proposal form. The District Consumer Commission, Kanker, accepted Savitri Salam's complaint and directed the insurance company to pay the full claim amount within one month. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List Undo SBI Life Insurance then challenged this order before the Chhattisgarh State Consumer Disputes Redressal Commission. During the appeal hearing, the bench of Justice Gautam Chourdiya, President, and Pramod Kumar Varma, Member, determined that the claim was rejected solely based on a note in the AIIMS, Raipur, medical record. No other medical records were presented to conclusively prove that the insured suffered from diabetes and heart disease before applying for the policy, had undergone any prior treatment, or was on continuous medication. The Commission observed there was no evidence to suggest that the insured was aware of these conditions when he submitted the proposal. The State Commission concluded that it was not appropriate to claim the insured intentionally concealed important facts about his pre-existing diseases in the proposal. The appeal was rejected, and SBI Life Insurance Company has been directed to pay Rs 50 lakh from the life insurance claim, after deducting the Rs 56,621 premium amount already refunded to Savitri Salam by the insurance company. This amount will also include 7% annual simple interest from the date the complaint was filed (27 December 2023).
Economic Times
12-06-2025
- Business
- Economic Times
Navigating Growth: Insights into the Life Insurance Sector
Sector Performance and Outlook Top Companies Analysts Recommend Based on Upside Potential Company Name Current Price Stock Score Recommendation Upside Potential Target Price Analyst Count Life Insurance Corporation Of India Rs. 964.8 8 Buy 12% Rs. 1,080.00 20 HDFC Life Insurance Company Rs. 765.1 7 Buy 8% Rs. 819.00 33 SBI Life Insurance Company Rs. 1,799.9 8 Buy 8% Rs. 1,940.00 32 Live Events Life Insurance Corporation Of India HDFC Life Insurance Company SBI Life Insurance Company (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel The life insurance sector has demonstrated remarkable resilience and growth potential in recent times. With a significant increase in performance over the past year, the sector is poised for further expansion. The recent repo rate cut by the Reserve Bank of India is expected to stimulate economic growth, enhancing liquidity and lowering borrowing costs for consumers and businesses. This policy shift is likely to boost lending activities and increase consumer spending, particularly benefiting small and medium enterprises(SMEs)and the insurance the sector continues to evolve, the positive sentiment among investors is reflected in the upward trajectory of stock prices. The overall outlook for the life insurance sector remains optimistic, with analysts projecting a healthy growth trajectory driven by increased demand for insurance products and services. The potential for credit growth and financial stability further supports this positive outlook, creating a conducive environment for investment and a maximum potential upside of 12% and a minimum of 8%, the sector is attracting attention from investors looking for growth opportunities. The combination of favorable economic policies and a growing awareness of the importance of life insurance is expected to drive the sector's performance in the coming years. Life Insurance Corporation of India is a prominent insurance company engaged in providing a wide range of life insurance products both in India and internationally. The company offers individual and group insurance solutions, including participating, non-participating, and unit-linked products. With a diverse portfolio that includes protection, pension, savings, investment, annuity, health, and variable products, LIC has established itself as a leader in the insurance recommend a 'Buy' for LIC, with a target price of Rs. 1,080.00, indicating a potential upside of 12%. The company's latest financial performance shows a sales figure of Rs. 339,305.63 Cr and a PAT of Rs. 20,895.05 Cr, reflecting a year-on-year PAT growth of 38.58% and a sales growth of 5.2%. Despite some fluctuations in the stock price over the past year, the overall outlook remains positive due to strong fundamentals and growth potential. HDFC Life Insurance Company Ltd is a leading life insurance provider in India, offering a comprehensive range of individual and group insurance solutions. The company's product portfolio includes protection, pension, savings, investment, annuity, and health plans. HDFC Life is known for its innovative products and customer-centric approach, catering to the diverse needs of its a stock score of 7, HDFC Life is also recommended as a 'Buy' with a target price of Rs. 819.00, presenting an upside potential of 8%. The latest financial results indicate sales of Rs. 24,661.87 Cr and a PAT of Rs. 392.02 Cr, with a year-on-year PAT growth of 2.7%. Although there has been a slight decline in sales growth, the company's strong market position and brand reputation continue to support its growth trajectory. SBI Life Insurance Company Limited is a prominent player in the Indian life insurance market, offering a wide array of life insurance products. The company operates through various segments, including participating, non-participating, and linked insurance products. SBI Life is recognized for its robust distribution network and innovative product offerings, catering to both individual and group have rated SBI Life as a 'Buy' with a target price of Rs. 1,940.00, indicating an upside potential of 8%. The company's latest financial performance shows sales of Rs. 23,630.97 Cr and a PAT of Rs. 429.07 Cr, with a year-on-year PAT growth of 18.05%. Despite a decline in sales growth, SBI Life's strong fundamentals and market presence position it well for future growth.
Business Standard
25-04-2025
- Business
- Business Standard
SBI Life rallies after Q4 PAT rises to Rs 814 crore
SBI Life Insurance Company jumped 4.48% to Rs 1,681 after the company's net profit rose marginally to Rs 813.51 crore in Q4 FY25 as against Rs 810.80 crore posted in Q4 FY24. However, total income dropped 35.66% YoY to Rs 24,169.41 crore in the quarter ended 31 March 2025. On a sequential basis, the company's net profit and revenue jumped by 47.69% and 30.34%, respectively, compared to Q3 FY25. The life insurer's net premium income declined 4.99% YoY to Rs 23,860.71 crore in Q4 FY25. However, the company reported a loss of Rs 1,040.83 crore from investments in the March quarter of FY25, compared to an investment income of Rs 10,811.70 crore in the same period of FY24. On a full-year basis, the company's net profit jumped by 27.43% to Rs 2,413.30 crore despite an 11.69% decline in total income to Rs 1,17,118.67 crore in FY25 over FY24. The companys net worth grew by 14% YoY to Rs 16,980 crore in FY25 as compared to Rs 14,910 crore recorded in FY24. SBI Life reported a robust solvency ratio of 1.96 as on 31 March 2025 as against the regulatory requirement of 1.50 indicating strong financial position of the company. Assets under management (AuM) grew by 15% YoY to Rs 4,48,040 crore as of 31 March 2025, with a debt-equity mix of 61:39. Over 94% of the debt investments are in AAA and sovereign instruments. Value of new business (VoNB) increased by 7% YoY to Rs 5,950 crore for FY25. VoNB margin reduced to 27.8% in FY25 as against 28.1% recorded in FY24. New business premium (NBP) slipped 7% YoY to Rs 35,580 crore in FY25. Gross written premium (GWP) grew 4% to 84,980 crore in FY25, mainly due to 11% growth in new business regular premium (RP) and 14% growth in renewal premium (RP) in FY25. The companys total cost ratio for FY25 was at 9.7% as compared with 8.9% reported in FY24. The commission ratio was at 4.4% in FY25 as against 4% in FY24. Operating expense ratio for FY25 was 5.3% as against 4.9% in FY24. Annualized premium equivalent (APE) stood at Rs 21,420 crore, registering growth of 9% YoY. SBI Life recorded strong growth in 13th-month and 61st-month persistency (based on premium considering regular premium/limited premium payment under the individual category) in FY25 by 63 bps and 528 bps respectively, due to our focus on improving the quality of business and customer retention. SBI Life Insurance Company is carrying on the business of life insurance. The company's life insurance business comprises individual life and group business, including participating, non-participating, pension, group gratuity, group leave encashment, group superannuation, group immediate annuity, unit-linked insurance products, variable insurance products, health, and microinsurance. Some of these policies have riders such as accident and disability benefit, level term, and critical illness.
